Catalent to acquire cell therapy company for $315M
Somerset-based drug delivery firm Catalent Inc. announced on Monday it has acquired MaSTherCell Global, a cell and gene therapy organization, for $315 million in cash. The acquisit…
Somerset-based drug delivery firm Catalent Inc. announced on Monday it has acquired MaSTherCell Global, a cell and gene therapy organization, for $315 million in cash. The acquisit…